Evaluation of Biosite Triage Clostridium difficile Panel for Rapid Detection of Clostridium difficile in Stool Samples

ABSTRACT One hundred two stool samples were tested by both the rapid TriageClostridium difficile Panel (Triage Panel) and the cytotoxin cell culture assay. Five samples positive by both theC. difficile toxin A (Tox A) and common antigen components of the Triage Panel had cytotoxin titers of ≥10,000. Twenty-three samples were Triage Panel Tox A negative but common antigen positive. Ten of these had cytotoxin titers of 10 to 1,000, but 13 were cytotoxin negative. Bacterial isolates obtained from 8 of these 13 specimens were analyzed for Tox A and B genes by PCR, and only two contained toxigenic bacteria. Thus, the majority of samples positive only for C. difficile common antigen contained nontoxigenic bacteria. A Triage Panel Tox A-positive result indicated a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 33.3, 100, 100, and 88.2%, respectively. A Triage Panel common antigen-positive result indicated a sensitivity, specificity, PPV, and NPV of 100, 82.7, 53.6, and 100%, respectively. The high NPV of the Triage Panel common antigen, together with rapid reporting of results, should prove useful in avoiding unnecessary use of contact precautions and antibiotic treatment for C. difficile-negative patients. However, with Triage Panel common antigen-positive patients, a sensitive cytotoxin assay should be used to distinguish true cytotoxin-positive patients from C. difficile carriers.

[1]  S. Meyers Clostridium difficile Colitis , 1999, American Journal of Gastroenterology.

[2]  C. Flexner,et al.  Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Samore,et al.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea , 1998, The Lancet.

[5]  R. Schwalbe,et al.  Multicenter Evaluation of the Clostridium difficileTOX A/B TEST , 1998, Journal of Clinical Microbiology.

[6]  M. Samore,et al.  Decreased risk of subsequent Clostridium difficile -Associated diarrhea (CDAD) in patients with primary asymptomatic colonization by CD , 1997 .

[7]  D. Gerding,et al.  Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  P. Gumerlock,et al.  Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Garner,et al.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. , 1996, Infection control and hospital epidemiology.

[10]  Richard D Moore,et al.  Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis , 1995, Annals of Internal Medicine.

[11]  P. Gumerlock,et al.  Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  L. Peterson,et al.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.

[13]  P. Gumerlock,et al.  Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. , 1991, Reviews of infectious diseases.

[14]  J. Verhoef,et al.  Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B , 1991, Journal of clinical microbiology.

[15]  B. Simmons,et al.  Guideline for isolation precautions in hospitals , 1984, American Journal of Infection Control.

[16]  J. Bartlett,et al.  Cytotoxicity assay in antibiotic-associated colitis. , 1979, The Journal of infectious diseases.